Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4
Open Access
- 1 April 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 8 (4) , 754-761
Abstract
Rhabdomyosarcoma is a tumor of striated muscle origin that displays defective myogenic differentiation. Terminal myogenesis switches off cell proliferation and migration, hence, the promotion of rhabdomyosarcoma differentiation should antagonize tumor growth and metastasis. Terminal myogenesis is controlled by cell-intrinsic myogenic transcription factors like myogenin and environmental mediators like interleukin 4 (IL-4). We studied whether the expression of myogenin or exposure to IL-4 could promote the myogenesis of poorly differentiating human rhabdomyosarcoma cells RD/12. Forced expression of myogenin amplified myosin expression and the formation of myotube-like elements, inhibited cell migration, and reduced the growth of local tumors and liver metastases in immunodepressed mice. In contrast, exposure to IL-4 promoted cell proliferation and survival, especially at high cell density, inhibited myogenin expression, and myogenesis. Moreover, IL-4 stimulated the directed migration of cells with low myogenin levels, but not of cells with higher (spontaneous or forced) levels. Thus, IL-4, which was known to promote late stages of normal myogenesis, favors growth and migration, and inhibits further differentiation of the myogenic stages attained by rhabdomyosarcoma cells. Strategies to increase myogenin expression and block IL-4 could simultaneously reduce growth and migration, and enhance terminal differentiation of rhabdomyosarcoma, thus contributing to the control of tumor growth and metastatic spread. [Mol Cancer Ther 2009;8(4):754–61]Keywords
This publication has 21 references indexed in Scilit:
- Crucial Role of Interleukin-4 in the Survival of Colon Cancer Stem CellsCancer Research, 2008
- Effects of PAX3-FKHR on malignant phenotypes in alveolar rhabdomyosarcomaBiochemical and Biophysical Research Communications, 2007
- Differential regulation of vascular endothelial growth factor by Akt and mammalian target of rapamycin inhibitors in cell lines derived from childhood solid tumorsMolecular Cancer Therapeutics, 2007
- Interleukin-4 improves the migration of human myogenic precursor cells in vitro and in vivoExperimental Cell Research, 2006
- Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas: Figure 1Journal of Clinical Pathology, 2003
- A caspase-8-independent component in TRAIL/Apo-2L-induced cell death in human rhabdomyosarcoma cellsCell Death & Differentiation, 2003
- LIGHT, a Member of the TNF Superfamily, Induces Morphological Changes and Delays Proliferation in the Human Rhabdomyosarcoma Cell Line RDBiochemical and Biophysical Research Communications, 2001
- Rhabdomyosarcoma – working out the pathwaysOncogene, 1999
- Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment.Journal of Cell Biology, 1989
- Embryonic myosin heavy chain as a differentiation marker of developing human skeletal muscle and rhabdomyosarcomaExperimental Cell Research, 1986